Schedule 13G ownership disclosure

Jade Biosciences Inc

Common Stock, $0.0001 par value per share · CUSIP: 008064206

Event date: 2025-04-28

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • TCG Crossover GP I, LLC

    Shares: 64,023 · Class: 0.2%

  • TCG Crossover Fund I, L.P.

    Shares: 64,023 · Class: 0.2%

  • Chen Yu

    Shares: 64,023 · Class: 0.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-072763
Form type
SCHEDULE 13G/A
Filer
Jade Biosciences, Inc.
CIK
CIK 1798749
Filed
May 15, 2025
Reporting period
Apr 28, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub